Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
J. David Enloe Jr currently holds 1,865,246 shares of Recro Pharma, Inc. (REPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, J. David Enloe Jr has been a net buyer of REPH stock. They have purchased $65.1K and sold $0 worth of shares.
J. David Enloe Jr's most recent insider trade was on Apr 8, 2024, when they sold 801,597 shares at $1.10 per share.
J. David Enloe Jr serves as Executive at Recro Pharma, Inc. (REPH). They have executed 33 insider transactions totaling $65.1K over their tenure at the company.
J. David Enloe Jr holds the position of Executive at Recro Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
J. David Enloe Jr has shown a buying trading pattern, with $65.1K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by J. David Enloe Jr was on Apr 8, 2024, when they sold $2.1M worth of SCTL shares. This transaction involved 1,865,246 shares at $1.10 per share.
J. David Enloe Jr currently owns 1,865,246 shares of Recro Pharma, Inc. (REPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of J. David Enloe Jr's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. J. David Enloe Jr has 33 Form 4 filings on record as an insider at Recro Pharma, Inc..
Set alerts for J. David Enloe Jr and 40,000+ other insiders.